In this interview, Alix Mayer explains why our children are being so aggressively targeted for the COVID-19 injection even though they’re not at risk of serious SARS-CoV-2 infection, and clarifies the status of Comirnaty.
Moderna plans to seek authorization for its pediatric COVID-19 vaccine for kids 6 and under, but experts say the vaccine maker’s trials for the young age group raise too many questions.
Global green financing, aimed at environmentally friendly projects around the world, has grown over 100 times in the past decade, a new study from the TheCityUK and BNP Paribas showed.
U.S. stocks edged lower on Thursday on worries about the raging conflict in Ukraine and the outlook for U.S. interest rate hikes, putting the main indexes on course for their worst quarter since the pandemic crash in 2020.
